PALATIN TECHNOLOGIES, INC. Payments to Acquire Marketable Securities
PALATIN TECHNOLOGIES, INC. (PTN) reported Payments to Acquire Marketable Securities of $2.99 million for the 12-month period ending 2023-06-30, per its 10-K filed 2023-09-28.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2023-09-28
- PALATIN TECHNOLOGIES, INC. payments to acquire marketable securities for fiscal 2023 was $2.99M.
- PALATIN TECHNOLOGIES, INC. payments to acquire marketable securities for fiscal 2022 was $0.00.
| Period end | Payments to Acquire Marketable Securities 12 month |
|---|---|
| 2023-06-30 | $2.99M 10-K · filed 2023-09-28 |
| 2022-06-30 | $0.00 10-K · filed 2023-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |